Top 5 Stocks to Buy Now
→ SpaceX will mint billionaires. You won't be one of them. (From Behind the Markets) (Ad)tc pixel Free NOEMW Stock Alerts

Noema Pharma (NOEMW) Competitors

Noema Pharma logo
$0.09 -0.01 (-5.95%)
As of 06/18/2026 03:58 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

NOEMW vs. SXTPW, DRTSW, APLMW, BIVIW, and CDIOW

Should you buy Noema Pharma stock or one of its competitors? MarketBeat compares Noema Pharma with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Noema Pharma include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). These companies are all part of the "biotechnology" industry.

How does Noema Pharma compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Noema Pharma (NASDAQ:NOEMW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, valuation, dividends, risk, media sentiment and earnings.

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
Noema Pharma N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A
Noema PharmaN/AN/AN/AN/AN/A

In the previous week, 60 Degrees Pharmaceuticals' average media sentiment score of 0.00 equaled Noema Pharma'saverage media sentiment score.

Company Overall Sentiment
60 Degrees Pharmaceuticals Neutral
Noema Pharma Neutral

Summary

60 Degrees Pharmaceuticals beats Noema Pharma on 1 of the 1 factors compared between the two stocks.

How does Noema Pharma compare to Alpha Tau Medical?

Noema Pharma (NASDAQ:NOEMW) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, earnings, analyst recommendations, institutional ownership, risk and valuation.

In the previous week, Noema Pharma's average media sentiment score of 0.00 equaled Alpha Tau Medical'saverage media sentiment score.

Company Overall Sentiment
Noema Pharma Neutral
Alpha Tau Medical Neutral

Company Net Margins Return on Equity Return on Assets
Noema PharmaN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Noema PharmaN/AN/AN/AN/AN/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

Summary

Noema Pharma and Alpha Tau Medical tied by winning 0 of the 0 factors compared between the two stocks.

How does Noema Pharma compare to Apollomics?

Apollomics (NASDAQ:APLMW) and Noema Pharma (NASDAQ:NOEMW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, media sentiment, profitability, valuation and analyst recommendations.

In the previous week, Apollomics' average media sentiment score of 0.00 equaled Noema Pharma'saverage media sentiment score.

Company Overall Sentiment
Apollomics Neutral
Noema Pharma Neutral

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
Noema Pharma N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
Noema PharmaN/AN/AN/AN/AN/A

Summary

Apollomics beats Noema Pharma on 1 of the 1 factors compared between the two stocks.

How does Noema Pharma compare to BioVie?

Noema Pharma (NASDAQ:NOEMW) and BioVie (NASDAQ:BIVIW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, earnings and media sentiment.

In the previous week, Noema Pharma's average media sentiment score of 0.00 equaled BioVie'saverage media sentiment score.

Company Overall Sentiment
Noema Pharma Neutral
BioVie Neutral

Company Net Margins Return on Equity Return on Assets
Noema PharmaN/A N/A N/A
BioVie N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Noema PharmaN/AN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Summary

Noema Pharma and BioVie tied by winning 0 of the 0 factors compared between the two stocks.

How does Noema Pharma compare to Cardio Diagnostics?

Noema Pharma (NASDAQ:NOEMW) and Cardio Diagnostics (NASDAQ:CDIOW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, media sentiment, analyst recommendations, risk, profitability and earnings.

In the previous week, Noema Pharma's average media sentiment score of 0.00 equaled Cardio Diagnostics'average media sentiment score.

Company Overall Sentiment
Noema Pharma Neutral
Cardio Diagnostics Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Noema PharmaN/AN/AN/AN/AN/A
Cardio Diagnostics$16.57KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Noema PharmaN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

Summary

Cardio Diagnostics beats Noema Pharma on 1 of the 1 factors compared between the two stocks.

Get Noema Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for NOEMW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NOEMW vs. The Competition

Export
MetricNoema PharmaBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$381.56M$6.43B$12.59B
Dividend YieldN/A3.86%2.68%5.81%
P/E RatioN/A3.1224.7524.42
Price / SalesN/A6,861.77529.99108.89
Price / CashN/A13.1345.0755.09
Price / BookN/A92.2610.806.58
Net IncomeN/A-$96.07M$3.57B$337.17M
7 Day PerformanceN/A0.88%0.72%0.83%
1 Month PerformanceN/A-0.66%0.41%2.25%
1 Year PerformanceN/A54.58%29.34%36.14%

Noema Pharma Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NOEMW
Noema Pharma
N/A$0.09
flat		N/AN/A$0.00N/AN/AN/A
SXTPW
60 Degrees Pharmaceuticals
N/A$0.04
-1.0%		N/A-37.3%$0.00$1.00MN/A2
DRTSW
Alpha Tau Medical
N/A$1.83
+1.4%		N/A+730.5%$0.00N/AN/A80
APLMW
Apollomics
N/A$0.01
+6.4%		N/A-26.2%$0.00$8.50MN/A59
BIVIW
BioVie
N/A$0.31
flat		N/AN/A$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:NOEMW) was last updated on 6/21/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
A huge SpaceX error just led one stock to 3X move!
SPCE surged roughly 300% in a single week after investors hunting SpaceX exposure piled into the wrong ticker....
InvestPub | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel